HB 717-FN (2020): prohibiting prescription drug manufacturers from offering coupons or discounts to cover insurance copayments or deductibles.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 717-FN (2020): prohibiting prescription drug manufacturers from offering coupons or discounts to cover insurance copayments or deductibles.” Granite Record, https://graniterecord.org/bill/2020/hb717. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 717-FN (2020): prohibiting prescription drug manufacturers from offering coupons or discounts to cover insurance copayments or deductibles. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb717
- Chicago
- Granite Record. “HB 717-FN (2020): prohibiting prescription drug manufacturers from offering coupons or discounts to cover insurance copayments or deductibles.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb717.
- BibTeX
@misc{bill-2020-hb717, title = {HB 717-FN (2020): prohibiting prescription drug manufacturers from offering coupons or discounts to cover insurance copayments or deductibles.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb717}, note = {Accessed 24 Oct. 2026} }
HB 717-FN (2020)
prohibiting prescription drug manufacturers from offering coupons or discounts to cover insurance copayments or deductibles.
- Status: Killed
- Term: 2019-2020
- House committee: Commerce and Consumer Affairs
- Senate committee: Commerce
- Subject: Insurance
The Story
It was introduced on January 3, 2019 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on March 5, 2019. The committee held a work session on March 6, 2019. The committee met in executive session on March 8, 2019 to vote on its recommendation. The committee held a work session on March 8, 2019. The minority of the committee recommended that the House kill it. The majority of the committee recommended that the House pass it with changes (amendment 2019-0932h) by a vote of 12–8, and the report was placed on the regular calendar. The committee's amendment (2019-0932h) was adopted on a voice vote on March 19, 2019, changing the text of the bill. On March 19, 2019 the House voted to pass it with changes on a roll call 198–144. It crossed to the Senate on March 28, 2019 and was referred to the Senate Commerce committee. The committee held a public hearing on May 9, 2019. The committee voted unanimously, 5–0, to recommend that the Senate send it back to committee, and the report was placed on the consent calendar. On May 23, 2019 the Senate voted to send it back to committee on a voice vote. The committee voted unanimously, 5–0, to recommend that the Senate kill it, and the report was placed on the consent calendar. On January 8, 2020 the Senate voted to kill it on a voice vote.
Sponsors
- Rep. Garrett Muscatel (D - Graf 12) (prime sponsor)
- Rep. William Marsh (D - Carr 8)
- Rep. David Luneau (D - Merr 10)
- Sen. Tom Sherman (D - SD24)
- Sen. Cindy Rosenwald (D - SD13)
- Sen. John Reagan (R - SD17)
Hearings and Sessions
- March 5, 2019, 1:30 PM: public hearing, House Commerce and Consumer Affairs, LOB 302
- March 6, 2019, 2:30 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
- March 8, 2019, 9:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
- March 8, 2019, 1:30 PM: executive session, House Commerce and Consumer Affairs, LOB 302-304
- May 9, 2019, 9:00 AM: hearing, Senate Commerce, LOB 102
Votes
- March 19, 2019, House: Ought to Pass with Amendment — yeas 198, nays 144, passed
- May 23, 2019, Senate: Rereferred to Committee — voice vote, passed
- January 8, 2020, Senate: Inexpedient to Legislate — voice vote, passed
The Docket
- January 3, 2019: Introduced 01/03/2019 and referred to Commerce and Consumer Affairs
- March 5, 2019: Public Hearing: 03/05/2019 01:30 pm LOB 302
- March 6, 2019: Subcommittee Work Session: 03/06/2019 02:30 pm LOB 302
- March 8, 2019: Executive Session: 03/08/2019 01:30 pm LOB 302-304
- March 8, 2019: Subcommittee Work Session: 03/08/2019 09:00 am LOB 302-304
- March 14, 2019: Minority Committee Report: Inexpedient to Legislate
- March 19, 2019: Majority Committee Report: Ought to Pass with Amendment #2019-0932h for 03/19/2019 (Vote 12-8; RC)
- March 19, 2019: Amendment #2019-0932h : AA VV 03/19/2019
- March 19, 2019: Ought to Pass with Amendment 2019-0932h: MA RC 198-144 03/19/2019
- March 28, 2019: Introduced 03/28/2019 and Referred to Commerce
- May 9, 2019: Hearing: 05/09/2019, Room 102, LOB, 09:00 am
- May 23, 2019: Committee Report: Rereferred to Committee, 05/23/2019; Vote 5-0; CC
- May 23, 2019: Rereferred to Committee, MA, VV; 05/23/2019
- January 8, 2020: Committee Report: Inexpedient to Legislate; Vote 5-0; CC; 01/08/2020
- January 8, 2020: Inexpedient to Legislate, MA, VV ; 01/08/2020
Laws It Would Change
Related Bills
- HB 1697-FN (2020): relative to prescription drug discount prohibition.